AI Image
Teen shares the impact taking a GLP-1 drug has on his daily life
ABC News - Breaking News, Latest News and Videos • • health
Key Points:
- Teenager Adam Renteria struggled with obesity and high blood pressure, impacting his independence and self-esteem, prompting his family to explore medical treatment options after diets and exercise proved ineffective.
- Adam was prescribed Wegovy, a GLP-1 drug approved by the FDA for treating obesity in children over 12, leading to significant improvements including a BMI reduction from 36 to 22.8 and increased physical activity such as joining a cheer team.
- Prescribing GLP-1 medications like Wegovy requires careful consideration of healthy lifestyle habits, potential side effects, and the likelihood of long-term use, with medical experts emphasizing the importance of experienced supervision and family support.
- Although use of GLP-1 drugs in children has increased substantially, researchers continue to study the long-term effects and outcomes when treatment is discontinued, highlighting that these medications are not quick fixes but part of ongoing management.
